Clincosm LogoSign in Get a demo

mucosal melanoma

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anal Melanoma, Bladder Melanoma, Cervical Melanoma Trial in United States (Cabozantinib S-malate, Nivolumab, Placebo

Recruiting
  • Anal Melanoma
  • +18 more
  • Cabozantinib S-malate
  • +5 more
  • Los Angeles, California
  • +53 more
Jan 31, 2023

Acral Lentiginous Melanoma, Cutaneous Nodular Melanoma, Lentigo Maligna Melanoma Trial in United States (Dinaciclib)

Active, not recruiting
Has Results
  • Acral Lentiginous Melanoma
  • +6 more
  • Mobile, Alabama
  • +190 more
Jan 28, 2023

Acral Lentiginous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in

Active, not recruiting
  • Acral Lentiginous Melanoma
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Birmingham, Alabama
  • +822 more
Jan 28, 2023

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV Trial in Iowa City, Rochester, Madison ([212Pb]VMT01)

Not yet recruiting
  • Melanoma (Skin)
  • +5 more
  • Iowa City, Iowa
  • +2 more
Dec 8, 2022

Mucosal Melanoma Trial in China (YH003, Pembrolizumab, albumin paclitaxel)

Recruiting
  • Mucosal Melanoma
  • Fuzhou, Fujian, China
  • +11 more
Oct 8, 2022

Cutaneous Melanoma, Uveal Melanoma, Mucosal Melanoma Trial in Worldwide (RO7293583, Tocilizumab, Obinutuzumab)

Completed
  • Cutaneous Melanoma
  • +2 more
  • Boston, Massachusetts
  • +13 more
Sep 30, 2022

Mucosal Melanoma Trial in Wollstonecraft (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Mucosal Melanoma
  • Wollstonecraft, New South Wales, Australia
    Melanoma Institute Australia
Sep 15, 2022

Advanced Melanoma, Melanoma of Unknown Primary, Mucosal Melanoma Trial in United States (Ipilimumab, Nivolumab)

Active, not recruiting
  • Advanced Melanoma
  • +10 more
  • Ipilimumab
  • Nivolumab
  • Anchorage, Alaska
  • +638 more
Aug 30, 2022

Cutaneous Melanoma, Mucosal Melanoma Trial in Worldwide (Nemvaleukin Alfa Subcutaneous, Nemvaleukin Alfa Intravenous)

Recruiting
  • Cutaneous Melanoma
  • Mucosal Melanoma
  • Nemvaleukin Alfa Subcutaneous
  • Nemvaleukin Alfa Intravenous
  • La Jolla, California
  • +26 more
Aug 1, 2022

Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

Not yet recruiting
  • Recurrent Metastatic Melanoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jul 29, 2022

Mucosal Melanoma Trial in New York (Nivolumab and/or Ipilimumab, Stereotactic Body Radiation Therapy (SBRT), axitinib)

Recruiting
  • Mucosal Melanoma
  • Nivolumab and/or Ipilimumab
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 14, 2022

Acral Melanoma, Mucosal Melanoma Trial in Seoul (Pembrolizumab, Vactosertib)

Not yet recruiting
  • Acral Melanoma
  • Mucosal Melanoma
  • Pembrolizumab, Vactosertib
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jun 23, 2022

Melanoma, Melanoma (Skin), Moles Trial in Nizhny Novgorod, Moscow (Non-invasive adhesive system (patch))

Recruiting
  • Melanoma
  • +11 more
  • Non-invasive adhesive system (patch)
  • Nizhny Novgorod, Russian Federation
  • +1 more
Jun 12, 2022

Cutaneous Melanoma, Melanoma, Melanoma of Unknown Primary Trial in United States (DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly

Completed
Has Results
  • Cutaneous Melanoma
  • +11 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +2 more
  • Chicago, Illinois
  • +6 more
Nov 10, 2021

Cutaneous Melanoma, Mucosal Melanoma, Ocular Melanoma Trial in New York, Houston (biological, other, procedure)

Active, not recruiting
  • Cutaneous Melanoma
  • +10 more
  • Ipilimumab
  • +4 more
  • New York, New York
  • +1 more
Aug 25, 2021

Mucosal Melanoma, Sinonasal Melanoma Trial in Shanghai (procedure, radiation, drug)

Recruiting
  • Mucosal Melanoma
  • Sinonasal Melanoma
  • endoscopic surgery
  • +2 more
  • Shanghai, Shanghai, China
    Eye& ENT Hospital, Fudan University
Aug 16, 2021

Melanoma, Metastatic Melanoma, Mucosal Melanoma Trial in Houston, Charlottesville (Peptide Vaccine (LPV7) + Tetanus peptide,

Unknown status
  • Melanoma
  • +2 more
  • Peptide Vaccine (LPV7) + Tetanus peptide
  • +3 more
  • Houston, Texas
  • +1 more
Nov 15, 2020

Mucosal Melanoma, Neoadjuvant Treatment Trial in Beijing (Lenvatinib, Pembrolizumab)

Not yet recruiting
  • Mucosal Melanoma
  • Neoadjuvant Treatment
  • Lenvatinib, Pembrolizumab
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 10, 2020

Mucosal Melanoma Trial in Shanghai (Toripalimab, chemo in combination with Endostar)

Recruiting
  • Mucosal Melanoma
  • Shanghai, Shanghai, China
    Zhiguo Luo
Jul 12, 2020

Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Mucosal Melanoma Trial in United States (Laboratory Biomarker

Completed
Has Results
  • Iris Melanoma
  • +19 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +147 more
Jun 24, 2020

Metastatic Melanoma, Mucosal Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (biological, other,

Completed
Has Results
  • Metastatic Melanoma
  • +4 more
  • Bevacizumab
  • +4 more
  • San Francisco, California
  • +12 more
Jan 7, 2020

Acral Lentiginous Melanoma, Mucosal Melanoma Trial in Washington, Tampa, Hackensack (Nivolumab, Ipilimumab)

Unknown status
  • Acral Lentiginous Melanoma
  • Mucosal Melanoma
  • Washington, District of Columbia
  • +3 more
Jan 7, 2020

Molecular Characterization of Primary Mucosal Melanoma

Unknown status
  • Mucosal Melanoma
  • Somatic Genetic
  • Reims, France
    Chu Reims
Dec 13, 2019

Mucosal Melanoma Trial in Guangzhou (RT)

Unknown status
  • Mucosal Melanoma
  • RT
  • Guangzhou, Guangdong, China
    LiXia Lu
Jan 27, 2018